| Dr Mark J Kushner, MD | |
|
110 Hospital Rd Ste 310, Prince Frederick, MD 20678-4041 | |
| (410) 535-2005 | |
| (410) 535-4850 |
| Full Name | Dr Mark J Kushner |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 110 Hospital Rd Ste 310, Prince Frederick, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023167673 | NPI | - | NPPES |
| 32905001 | Other | MD | CAREFIRST OF MARYLAND |
| 336799 | Other | MD | MAMSI HMO |
| 2154481 | Other | MD | AETNA HMO SPECIALIST |
| 7720001 | Other | MD | AETNA NON-HMO SPECIALIST |
| C0410006 | Other | DC | CAREFIRST OF DC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | D23468 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark J Kushner, MD 110 Hospital Rd Ste 310, Prince Frederick, MD 20678-4041 Ph: (410) 535-2005 | Dr Mark J Kushner, MD 110 Hospital Rd Ste 310, Prince Frederick, MD 20678-4041 Ph: (410) 535-2005 |
News Archive
Celsis In Vitro, Inc. announced today that it has filed a patent infringement lawsuit against XenoTech LLC, Sekisui Chemical Co. Ltd., and Sekisui Medical Co. Ltd. in the United States District Court for the Northern District of Illinois in Chicago. XenoTech and Sekisui Medical are wholly-owned subsidiaries of Sekisui Chemical.
In the early 90s, Dr. Jessie Casida was one of few nurses working on the first patient with a left ventricular assist device-;a battery-powered device that pumps blood, surgically implanted into the heart of patients who have end-stage heart failure.
CEA-Leti today announced the launch of the TARGET-PDT project designed to increase the effectiveness of photodynamic therapy for treating cancer by developing a novel nano carrier-based approach.
Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a negative opinion on its Marketing Authorisation Application (MAA) for the antibiotic ZEFTERA(TM) (ceftobiprole medocaril), for the treatment of complicated skin and soft tissue infections.
A new study has found that protein and not sugar activates the cells responsible for keeping us awake and burning calories. The research, published in the 17 November issue of the scientific journal Neuron, has implications for understanding obesity and sleep disorders.
› Verified 1 days ago
Julie O'keefe, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 985 Prince Frederick Blvd Ste 201, Prince Frederick, MD 20678 Phone: 410-535-2005 Fax: 410-535-4850 | |
Dr. Jonathan Kim Fears, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 985 Prince Frederick Blvd Ste 201, Prince Frederick, MD 20678 Phone: 410-535-2005 Fax: 410-535-4850 | |
Cassius Diego Belfonte, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 110 Hospital Rd, Suite 306, Prince Frederick, MD 20678 Phone: 410-414-6559 Fax: 410-414-5332 | |
Dr. Bilal Ahmed, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 110 Hospital Rd, Suite 105, Prince Frederick, MD 20678 Phone: 410-414-9116 Fax: 410-414-9118 | |
Dr. Reena Mary Thomas, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 205 Steeple Chase Dr 307, Prince Frederick, MD 20678 Phone: 443-432-3020 Fax: 410-486-7178 | |
Dr. Joseph John Barth Iii, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 110 Hospital Rd Ste 310, Prince Frederick, MD 20678 Phone: 410-535-2005 Fax: 410-535-4850 |